Company Viofarm Srl with Fiscal Code 3199391
recorded a turnover of 2024 of
208.391,
with a net profit of
-231
and having an average number of employees of
4.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Viofarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
182.850
295.010
295.651
295.166
286.517
280.234
252.296
232.835
212.297
208.391
Total Income - EUR
189.891
298.733
299.827
297.236
288.399
283.185
255.480
233.138
218.941
209.075
Total Expenses - EUR
189.421
281.341
287.465
284.839
285.471
268.337
234.238
216.880
202.993
209.284
Gross Profit/Loss - EUR
470
17.392
12.362
12.396
2.928
14.848
21.242
16.258
15.948
-209
Net Profit/Loss - EUR
152
13.721
7.872
9.428
44
12.203
18.917
14.230
13.802
-231
Employees
4
5
5
5
6
6
5
4
4
4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -1.3%, from 212.297 euro in the year 2023, to 208.391 euro in 2024.
The Net Profit decreased by -13.725 euro, from 13.802 euro in 2023, to 0 in the last year.
Check the financial reports for the company - Viofarm Srl
Financial Rating - VIOFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Viofarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Viofarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Viofarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
125.872 euro in 2024 which includes Inventories of
27.623 euro, Receivables of
91.368 euro and cash availability of
6.881 euro.
The company's Equity was valued at
82.708 euro, while total Liabilities amounted to
60.384 euro.
Equity decreased by -231 euro, from 83.405 euro in 2023, to 82.708 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Viofarm Srl